Tirzepatide Dose Escalation: The Standard Protocol

Standard dose escalation schedule

Compounded tirzepatide protocols typically start at 2.5 mg/week and increase by 2.5 mg every 4 weeks until reaching the target maintenance dose. Most prescribers target 10–15 mg/week for body composition goals; 5–10 mg/week for glycemic control. Your specific escalation is set by your prescribing provider.

Not everyone reaches 15 mg. Many users achieve their goals at 10–12.5 mg and stay there. Some tolerate 15 mg and need it for maximum effect. The right dose is the one your provider has you on, not the highest available.

Why slow escalation matters

Gastrointestinal side effects — nausea, vomiting, diarrhea — are the primary reason tirzepatide protocols are abandoned early. These effects are almost entirely dose-dependent and front-loaded: they're worst during escalation steps and improve once the body adapts.

Rushing escalation dramatically increases the probability of intolerable GI effects. A 4-week hold at each dose level gives the GI tract time to adapt. Some providers use 6-week hold periods for patients who are more sensitive.

If you experience severe GI effects at a new dose, your provider may pause escalation and hold the current dose for another 4 weeks before trying to increase again — or reduce to the previous dose and re-attempt escalation more slowly.

The tracking problem with escalation

Every escalation step changes the number of units you draw. This is the specific failure mode that makes dose escalation dangerous without a tracker:

• You escalate from 5 mg to 7.5 mg. On a 5 mg/mL vial, your draw changes from 100 units to 150 units — a 50% increase.
• If you forgot to update your calculation and draw 100 units thinking it's 7.5 mg, you've taken 5 mg instead — you haven't escalated.
• If you drew 150 units at the old 5 mg/mL dose thinking you're still at 5 mg, you've taken 7.5 mg early — you've escalated by accident.

My Pep Calc stores the current target dose per compound. When you escalate, you update the dose in the app and the calculator immediately reflects the new units. Your historical doses remain in the log unchanged so you can see the escalation timeline clearly.

Units to draw at each escalation step

The units you draw depend on your vial concentration. Common pre-mixed concentrations and draws per escalation step:

Use the tirzepatide calculator with your specific vial concentration for precise units. Confirm your vial concentration with your pharmacy before each dose escalation.

Missed doses during escalation

Tirzepatide's ~5-day half-life gives some buffer for missed doses. Clinical guidelines for the brand-name version (Mounjaro/Zepbound) specify:

• If your next scheduled dose is more than 4 days away: take the missed dose as soon as possible, then resume your regular weekly schedule.
• If your next scheduled dose is 4 days away or less: skip the missed dose and resume on your regular schedule.

For compounded tirzepatide, follow your prescribing provider's guidance, which may differ slightly. My Pep Calc's dose log timestamps every injection, making it easy to calculate where you are in your schedule after a missed dose.

When escalation stalls or reverses

It is normal for escalation to pause or temporarily reverse. Reasons include: intolerable GI effects, illness, travel disrupting routine, or provider discretion. Some users successfully dose-reduce during stressful periods and re-escalate when conditions improve.

The dose log in My Pep Calc records every change so your escalation history is visible to your provider — a useful clinical record that a notes app won't produce.